» Articles » PMID: 36594503

The Effect of the Size of the New Contour Neurovascular Device for Altering Intraaneurysmal Flow

Overview
Publisher Sage Publications
Specialty Neurology
Date 2023 Jan 3
PMID 36594503
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, a novel intrasaccular device (contour neurovascular system, contour) was introduced to treat intracranial aneurysms. Contour is placed at thе aneurysm neck and reduces the intraaneurysmal blood inflow. Contour comes in a range of sizes to target different aneurysms. The efficiency of altering flow with contour and the effect of device size have not yet been investigated. Therefore, we studied the effect of the device size with patient-based aneurysm models using 2D digital subtraction angiography (DSA).

Methods: Three patient-based aneurysm models with necks ranging from 2.7 to 9.7 mm were produced, providing standardized testing conditions. Contours with diameters of 5, 11, and 14 mm were implanted into the models, four of each size. 2D DSA images were acquired before and after implanting contour (15 frames/s, manual contrast injection). After injecting angiographic contrast agent, the DSA signal was recorded over time to calculate the contrast washout time (WOT), which is a measure of flow diversion efficiency.

Results: All contour devices caused contrast agent stasis and increased WOT in aneurysm sac (-value = 0.0005). The median relative WOT was largest for 5-mm contour (6.6 ± 3.2) and similar for 11-mm contour (3.4 ± 2.6) and 14-mm contour (3.2 ± 3.8). The implantation procedure might affect WOT values even for contours of the same size; the overall relative WOT ranged between 1.5 and 10.89.

Conclusion: The 5-mm contour showed the longest WOT value in our study, while no apparent difference between 11-mm contour and 14-mm contour was found.

Citing Articles

Non-invasive follow-up for intracranial aneurysms treated with contour neurovascular system-comparison of digital subtraction angiography (DSA) to magnetic resonance imaging (MRI) and spectral computed tomography angiography (CTA) in vitro.

Madjidyar J, Pravdivtseva M, Hensler J, Jansen O, Larsen N, Wodarg F Interv Neuroradiol. 2024; :15910199241277907.

PMID: 39219551 PMC: 11569776. DOI: 10.1177/15910199241277907.


Endovascular treatment of aneurysm remnants with the Contour Neurovascular System after previous treatment.

Goertz L, Radomi A, Forbrig R, Pflaeging M, Kabbasch C, Liebig T Interv Neuroradiol. 2024; :15910199241264871.

PMID: 39091055 PMC: 11569726. DOI: 10.1177/15910199241264871.


In vitro and in silico assessment of flow modulation after deploying the Contour Neurovascular System in intracranial aneurysm models.

Korte J, Gaidzik F, Larsen N, Schutz E, Damm T, Wodarg F J Neurointerv Surg. 2023; 16(8):815-823.

PMID: 37852752 PMC: 11287554. DOI: 10.1136/jnis-2023-020403.

References
1.
Sadasivan C, Dholakia R, Peeling L, Golitz P, Doerfler A, Lieber B . Angiographic assessment of the efficacy of flow diverter treatment for cerebral aneurysms. Interv Neuroradiol. 2019; 25(6):655-663. PMC: 6838848. DOI: 10.1177/1591019919860829. View

2.
Sadasivan C, Lieber B, Gounis M, Lopes D, Hopkins L . Angiographic quantification of contrast medium washout from cerebral aneurysms after stent placement. AJNR Am J Neuroradiol. 2002; 23(7):1214-21. PMC: 8185722. View

3.
Rayz V, Boussel L, Ge L, Leach J, Martin A, Lawton M . Flow residence time and regions of intraluminal thrombus deposition in intracranial aneurysms. Ann Biomed Eng. 2010; 38(10):3058-69. PMC: 2940011. DOI: 10.1007/s10439-010-0065-8. View

4.
Chodzyski K, Uzureau P, Nuyens V, Rousseau A, Coussement G, Boudjeltia K . The impact of arterial flow complexity on flow diverter outcomes in aneurysms. Sci Rep. 2020; 10(1):10337. PMC: 7316819. DOI: 10.1038/s41598-020-67218-9. View

5.
Zarrinkoob L, Ambarki K, Wahlin A, Birgander R, Eklund A, Malm J . Blood flow distribution in cerebral arteries. J Cereb Blood Flow Metab. 2015; 35(4):648-54. PMC: 4420884. DOI: 10.1038/jcbfm.2014.241. View